Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arturo Orlacchio

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|December 10, 2021
The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer PathophysiologyArturo Orlacchio, Pellegrino Mazzone
International Review of Cell and Molecular Biology|February 15, 2024
Epigenetic therapeutic strategies in pancreatic cancerArturo Orlacchio, Stephen Muzyka, Tamas A Gonda
Microorganisms|June 2, 2021
Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced OncogenesisShimaa Hassan AbdelAziz Soliman, Arturo Orlacchio, Fabio Verginelli
Case Reports in Oncology|December 1, 2025
Continuous Regression of Metastatic Pancreatic Adenocarcinoma after Suspending Chemotherapy: A Case ReportLeyla Bayat, Arturo Orlacchio, Daniel Parrott, et al.
Frontiers in Immunology|June 17, 2022
Understanding Tricky Cellular and Molecular Interactions in Pancreatic Tumor Microenvironment: New Food for ThoughtAntonio Agostini, Arturo Orlacchio, Carmine Carbone, et al.
Pharmaceuticals (Basel, Switzerland)|December 3, 2020
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC TherapyIlaria Guerriero, Gianni Monaco, Vincenzo Coppola, et al.
Cancer Letters|September 24, 2018
PI3K blockage synergizes with PLK1 inhibition preventing endoreduplication and enhancing apoptosis in anaplastic thyroid cancerDaniela De Martino, Emrullah Yilmaz, Arturo Orlacchio, et al.
Oncotarget|May 5, 2016
Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosisDevora Champa, Arturo Orlacchio, Bindi Patel, et al.
Cancer Research|October 22, 2017
SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and MaintenanceArturo Orlacchio, Michela Ranieri, Martina Brave, et al.
Journal of Cancer Metastasis and Treatment|November 15, 2021
RANBP9 as potential therapeutic target in non-small cell lung cancerAnna Tessari, Shimaa H A Soliman, Arturo Orlacchio, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|December 10, 2021
The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer PathophysiologyArturo Orlacchio, Pellegrino Mazzone
International Review of Cell and Molecular Biology|February 15, 2024
Epigenetic therapeutic strategies in pancreatic cancerArturo Orlacchio, Stephen Muzyka, Tamas A Gonda
Microorganisms|June 2, 2021
Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced OncogenesisShimaa Hassan AbdelAziz Soliman, Arturo Orlacchio, Fabio Verginelli
Case Reports in Oncology|December 1, 2025
Continuous Regression of Metastatic Pancreatic Adenocarcinoma after Suspending Chemotherapy: A Case ReportLeyla Bayat, Arturo Orlacchio, Daniel Parrott, et al.
Frontiers in Immunology|June 17, 2022
Understanding Tricky Cellular and Molecular Interactions in Pancreatic Tumor Microenvironment: New Food for ThoughtAntonio Agostini, Arturo Orlacchio, Carmine Carbone, et al.
Pharmaceuticals (Basel, Switzerland)|December 3, 2020
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC TherapyIlaria Guerriero, Gianni Monaco, Vincenzo Coppola, et al.
Cancer Letters|September 24, 2018
PI3K blockage synergizes with PLK1 inhibition preventing endoreduplication and enhancing apoptosis in anaplastic thyroid cancerDaniela De Martino, Emrullah Yilmaz, Arturo Orlacchio, et al.
Oncotarget|May 5, 2016
Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosisDevora Champa, Arturo Orlacchio, Bindi Patel, et al.
Cancer Research|October 22, 2017
SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and MaintenanceArturo Orlacchio, Michela Ranieri, Martina Brave, et al.
Journal of Cancer Metastasis and Treatment|November 15, 2021
RANBP9 as potential therapeutic target in non-small cell lung cancerAnna Tessari, Shimaa H A Soliman, Arturo Orlacchio, et al.
Pageof 2